I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with extensive experience in technology, innovation, and research and development within the industry. Today, we’re diving into the exciting world of biomanufacturing, focusing on a groundbreaking new lab at a prominent
In a stunning revelation that has sent ripples through the medical community, a recent study published in The New England Journal of Medicine has uncovered a direct link between a widespread skin virus and the development of a common form of skin cancer. The research spotlights betapapillomavirus
In a world where genetic diseases like neuromuscular disorders have long defied effective treatment, a staggering statistic emerges: over 7,000 rare diseases affect millions globally, with many lacking viable therapies, spurring a transformative wave in biopharmaceutical innovation. This wave is
The landscape of medical treatment has been profoundly transformed by biologics—complex therapies like monoclonal antibodies, recombinant proteins, and nucleic acid-based solutions that target diseases with remarkable precision. Despite their groundbreaking impact, a significant challenge persists:
In a landscape where rare diseases often struggle for attention and innovation, cutaneous T-cell lymphoma (CTCL)—encompassing mycosis fungoides (MF) and Sézary syndrome (SS)—stands as a stark reminder of unmet medical needs. With only a small fraction of cancer cases attributed to these conditions,
The pharmaceutical industry stands at a critical crossroads, grappling with the staggering statistic that developing a single new drug can cost upwards of $2.6 billion and take over a decade from discovery to market, pushing the sector to seek groundbreaking solutions. Artificial Intelligence (AI)
